Function Health Honored by Goldman Sachs for Entrepreneurship

15.10.25 14:00 Uhr

Werte in diesem Artikel
Aktien

665,90 EUR 7,70 EUR 1,17%

Jonathan Swerdlin, Co-Founder & CEO, Among the Most Exceptional Entrepreneurs at 2025 Builders and Innovators Summit

NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Today, Goldman Sachs (NYSE: GS) is recognizing Function Health Co-Founder & CEO Jonathan Swerdlin as one of the Most Exceptional Entrepreneurs of 2025 at its Builders and Innovators Summit in Healdsburg, California.

Function Health Logo (PRNewsfoto/Function Health)

Goldman Sachs selected Jonathan from multiple industries to be honored at the two-day event. Jonathan is the co-founder and CEO of Function, a proactive healthcare platform that helps you see your health clearly. The platform includes access to over 100 lab tests and advanced MRI and CT imaging powered by FDA-cleared AI. Together, these tests and scans provide a comprehensive view of your body, helping detect early signs of disease — from heart and hormone issues to cancer and brain health concerns — before symptoms appear. Driven by a life mission to empower everyone to live 100 healthy years, Jonathan is a fierce advocate for leveraging technology to reduce unnecessary suffering and feel your best.

"Being recognized by Goldman Sachs alongside such inspiring entrepreneurs is an honor," said Jonathan. "Function is driven by its 100 health years mission. Honors like these are evidence that our mission is being realized and not just an idea sitting in a pitch deck. "

"We are pleased to recognize Jonathan Swerdlin as one of the most exceptional entrepreneurs of 2025," said David Solomon, Chairman and CEO of Goldman Sachs. "The Function Health team have not only built a successful enterprise, they are redefining industry paradigms. This year's Summit has brought together many of the best business minds to talk about harnessing the full potential of AI and building the next generation of businesses."

In its 14th year, Goldman's Builders and Innovators Summit is the can't miss gathering for Founders and CEOs of hypergrowth companies. Previous honorees have gone on to lead multi-billion dollar companies, both in the private and public markets. In addition to honoring the most exceptional entrepreneurs each year, the Summit consists of general sessions and clinics led by seasoned entrepreneurs, academics and business leaders as well as resident scholars.

About Function Health
Function is the first health platform to include access to 100+ lab tests, helping individuals understand their whole body—from heart and hormones to thyroid, nutrients, toxins, autoimmunity, immunity, and beyond. Unlike traditional testing, which is often costly, inaccessible, and done reactively, Function offers access to comprehensive testing along with detailed and actionable insights from the world's top doctors at just $499 per year. This is eight times more lab testing than a typical physical, which averages 19 labs tests and may miss critical aspects of your health. All results and insights are continuously tracked and securely stored in Function's platform, allowing individuals to uncover trends and watch health transformations over time. Since mid-2023, nearly 200,000 members have joined Function.

About Goldman Sachs
Goldman Sachs is a leading global financial institution that delivers a broad range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Founded in 1869, the firm is headquartered in New York and maintains offices in all major financial centers around the world.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/function-health-honored-by-goldman-sachs-for-entrepreneurship-302584493.html

SOURCE Function Health

In eigener Sache

Übrigens: Goldman Sachs und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Goldman Sachs

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Goldman Sachs

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Goldman Sachs

Wer­bung

Analysen zu Goldman Sachs

DatumRatingAnalyst
14.10.2025Goldman Sachs Sector PerformRBC Capital Markets
15.01.2025Goldman Sachs Sector PerformRBC Capital Markets
15.01.2025Goldman Sachs NeutralUBS AG
15.01.2025Goldman Sachs OverweightJP Morgan Chase & Co.
06.01.2025Goldman Sachs NeutralUBS AG
DatumRatingAnalyst
15.01.2025Goldman Sachs OverweightJP Morgan Chase & Co.
16.10.2024Goldman Sachs BuyJefferies & Company Inc.
15.10.2024Goldman Sachs OverweightJP Morgan Chase & Co.
15.07.2024Goldman Sachs BuyJefferies & Company Inc.
16.01.2024Goldman Sachs BuyJefferies & Company Inc.
DatumRatingAnalyst
14.10.2025Goldman Sachs Sector PerformRBC Capital Markets
15.01.2025Goldman Sachs Sector PerformRBC Capital Markets
15.01.2025Goldman Sachs NeutralUBS AG
06.01.2025Goldman Sachs NeutralUBS AG
15.07.2024Goldman Sachs Sector PerformRBC Capital Markets
DatumRatingAnalyst
19.10.2017Goldman Sachs SellSociété Générale Group S.A. (SG)
24.02.2017Goldman Sachs SellJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.01.2017Goldman Sachs SellCitigroup Corp.
06.05.2016Goldman Sachs SellSociété Générale Group S.A. (SG)
01.03.2016Goldman Sachs SellSociété Générale Group S.A. (SG)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Goldman Sachs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen